These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert JW. Am J Kidney Dis; 2005 Aug 17; 46(2):253-62. PubMed ID: 16112043 [Abstract] [Full Text] [Related]
14. [Goodpasture's syndrome with neurologic involvement and negative ANCA]. Pérez-Suárez G, Marrero D, Rodríguez R, Delgado P, Cobo M, González-Posada JM, Hernández D. Nefrologia; 2010 Aug 17; 30(5):584-7. PubMed ID: 20613848 [Abstract] [Full Text] [Related]
15. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies. Yang R, Hellmark T, Zhao J, Cui Z, Segelmark M, Zhao MH, Wang HY. J Am Soc Nephrol; 2007 Apr 17; 18(4):1338-43. PubMed ID: 17329569 [Abstract] [Full Text] [Related]
20. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study. Andreiana I, Stancu S, Avram A, Taran L, Mircescu G. BMC Nephrol; 2015 Jun 30; 16():90. PubMed ID: 26123651 [Abstract] [Full Text] [Related] Page: [Next] [New Search]